Futian Tang Selected Research

astragaloside A

1/2022	Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats.
1/2018	Calcium Sensing Receptor-Related Pathway Contributes to Cardiac Injury and the Mechanism of Astragaloside IV on Cardioprotection.
4/2016	Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
11/2015	Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation.
4/2015	Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
1/2015	Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Futian Tang Research Topics

Disease

10	Atherosclerosis 01/2022 - 10/2005
9	Cardiomegaly (Heart Hypertrophy) 07/2019 - 05/2007
8	Inflammation (Inflammations) 01/2022 - 09/2015
7	Body Weight (Weight, Body) 01/2022 - 12/2006
6	Neoplasms (Cancer) 01/2022 - 01/2021
3	Fibrosis (Cirrhosis) 01/2020 - 04/2007
3	Hypertrophy 01/2018 - 01/2015
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2017 - 04/2015
2	Hypercholesterolemia 01/2015 - 10/2005
1	Headache (Headaches) 01/2022
1	Neuroblastoma 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Stroke (Strokes) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Hemorrhage 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 10/2021
1	Carcinogenesis 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2021
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Heart Injuries 06/2021
1	Infections 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020
1	Hyperglycemia 01/2020
1	Anemia 12/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Lentivirus Infections 01/2018
1	Heart Diseases (Heart Disease) 11/2015

Drug/Important Bio-Agent (IBA)

8	Messenger RNA (mRNA)IBA 01/2022 - 10/2005
7	CholesterolIBA 01/2022 - 02/2010
6	astragaloside AIBA 01/2022 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2005
5	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2011
5	ApolipoproteinsIBA 01/2022 - 11/2011
5	Atrial Natriuretic Factor (ANF)IBA 01/2020 - 01/2015
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2016 - 01/2015
3	LipidsIBA 01/2022 - 10/2005
3	AntioxidantsIBA 01/2020 - 10/2005
3	Cysteine Proteases (Cysteine Protease)IBA 07/2019 - 01/2015
3	Simvastatin (Zocor)FDA LinkGeneric 02/2019 - 12/2016
3	tanshinoneIBA 08/2012 - 11/2011
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2020
2	LipopolysaccharidesIBA 01/2022 - 12/2018
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 12/2006
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020 - 12/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 02/2015
2	acetylleucyl-leucyl-norleucinalIBA 01/2018 - 01/2015
2	Polysaccharides (Glycans)IBA 06/2017 - 05/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016 - 05/2015
2	Adenosine Triphosphate (ATP)IBA 05/2015 - 01/2015
2	Adenosine Monophosphate (AMP)IBA 05/2015 - 01/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2015 - 01/2015
2	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 01/2015 - 02/2010
2	oxidized low density lipoproteinIBA 01/2015 - 01/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	MesothelinIBA 01/2022
1	Cilostazol (Pletal)FDA LinkGeneric 01/2022
1	Autophagy-Related ProteinsIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	ImmunosorbentsIBA 01/2022
1	epidermal growth factor receptor VIIIIBA 01/2022
1	calpain inhibitorsIBA 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 10/2021
1	Small Interfering RNA (siRNA)IBA 10/2021
1	Long Noncoding RNAIBA 10/2021
1	CalciumIBA 06/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	InterleukinsIBA 01/2021
1	CytokinesIBA 01/2021
1	Streptozocin (Streptozotocin)FDA Link 07/2019
1	lycium barbarum polysaccharideIBA 07/2019
1	Interleukin-18 (Interleukin 18)IBA 12/2018
1	HepcidinsIBA 12/2018
1	IronIBA 12/2018
1	metal transporting protein 1 (ferroportin)IBA 12/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2018
1	CalpainIBA 01/2018
1	CalcineurinIBA 01/2018
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2018
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2017
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 12/2016
1	NF-kappa B (NF-kB)IBA 10/2016
1	ginsenoside Rg1IBA 10/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2015
1	Nonesterified Fatty Acids (NEFA)IBA 05/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2021
3	Immunotherapy 01/2021 - 01/2021
1	Oral Administration 10/2016
1	Intraperitoneal Injections 09/2015